Synergistic antitumor effect of bispecific CD19 x CD3 and CD19 x CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma (Q40723305)
Jump to navigation
Jump to search
scientific article published on July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Synergistic antitumor effect of bispecific CD19 x CD3 and CD19 x CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma |
scientific article published on July 2002 |
Statements
1 reference
Synergistic antitumor effect of bispecific CD19 x CD3 and CD19 x CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma (English)
1 reference
Gerhard Moldenhauer
1 reference
Stefan Knackmuss
1 reference
Sergey M Kipriyanov
1 reference
Björn Cochlovius
1 reference
Holger J Schäfer
1 reference
Alexandra Bähre
1 reference
Fabrice Le Gall
1 reference
Melvyn Little
1 reference
1 July 2002
1 reference
1 reference
Identifiers
1 reference